Methods of minimal residual disease (MRD) detection in childhood haematological malignancies (Q36726108)

15 August 2017

1 reference

title

Methods of minimal residual disease (MRD) detection in childhood haematological malignancies (English)

1 reference

15 August 2017

author

Małgorzata Dawidowska

series ordinal

3

object named as

Małgorzata Dawidowska

1 reference

15 August 2017

2

Katarzyna Derwich

1 reference

15 August 2017

Justyna Jółkowska

1

1 reference

15 August 2017

publication date

1 January 2007

1 reference

Journal of Applied Genetics

15 August 2017

published in

1 reference

15 August 2017

volume

48

1 reference

15 August 2017

issue

1

1 reference

15 August 2017

page(s)

77-83

1 reference

Minimal residual disease (MRD) status prior to allogeneic stem cell transplantation is a powerful predictor for post-transplant outcome in children with ALL.

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF03194661

Wilms' tumor gene 1 (WT1) expression in childhood acute lymphoblastic leukemia: a wide range of WT1 expression levels, its impact on prognosis and minimal residual disease monitoring.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03194661

Detection of minimal residual disease in acute leukemia by flow cytometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03194661

Prognostic role of minimal residual disease in multiple myeloma patients after non-myeloablative allogeneic transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03194661

Serial monitoring of BCR-ABL transcripts in chronic myelogenous leukemia (CML) treated with imatinib mesylate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03194661

Beyond detectable minimal residual disease in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03194661

Simplified sensitive method for the detection of B-cell clonality in lymphoid malignancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03194661

Cytogenetic and molecular monitoring of residual disease in chronic myeloid leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03194661

High WT1 expression after induction therapy predicts high risk of relapse and death in pediatric acute myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03194661

Detection of minimal residual disease in acute myelogenous leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03194661

Detection and monitoring of minimal residual disease by quantitative real-time PCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03194661

Identification of a set of seven genes for the monitoring of minimal residual disease in pediatric acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03194661

Minimal residual disease in leukaemia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03194661

Minimal residual disease post-bone marrow transplantation for hemato-oncological diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03194661

Minimal residual disease detection after allogeneic stem cell transplantation is correlated to relapse in patients with acute lymphoblastic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03194661

Detection of minimal residual disease in hematologic malignancies by real-time quantitative PCR: principles, approaches, and laboratory aspects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03194661

Impact of two independent bone marrow samples on minimal residual disease monitoring in childhood acute lymphoblastic leukaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03194661

Monitoring of minimal residual disease (MRD) by real-time quantitative reverse transcription PCR (RQ-RT-PCR) in childhood acute myeloid leukemia with AML1/ETO rearrangement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03194661

Detection of minimal residual disease identifies differences in treatment response between T-ALL and precursor B-ALL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03194661

Combined use of reverse transcriptase polymerase chain reaction and flow cytometry to study minimal residual disease in Philadelphia positive acute lymphoblastic leukemia

21 January 2018

1 reference

12 December 2020

The TEL-AML1 real-time quantitative polymerase chain reaction (PCR) might replace the antigen receptor-based genomic PCR in clinical minimal residual disease studies in children with acute lymphoblastic leukaemia

1 reference

12 December 2020

Competitive polymerase chain reaction to estimate the number of BCR-ABL transcripts in chronic myeloid leukemia patients after bone marrow transplantation

1 reference

12 December 2020

Minimal residual disease testing of acute leukemia by flow cytometry immunophenotyping: a retrospective comparison of detection rates with flow cytometry DNA ploidy or FISH-based methods

1 reference

12 December 2020

Wilms' tumour gene (wt1) expression at diagnosis has no prognostic relevance in childhood acute lymphoblastic leukaemia treated by an intensive chemotherapy protocol

1 reference

12 December 2020

Minimal residual disease directed therapy for childhood acute myeloid leukaemia: the time is now

1 reference

12 December 2020

Rapid and reliable quantification of minimal residual disease in acute lymphoblastic leukemia using rearranged immunoglobulin and T-cell receptor loci by LightCycler technology

1 reference

12 December 2020

Use of peripheral blood instead of bone marrow to monitor residual disease in children with acute lymphoblastic leukemia

1 reference

12 December 2020

Four-color flow cytometry bypasses limitations of IG/TCR polymerase chain reaction for minimal residual disease detection in certain subsets of children with acute lymphoblastic leukemia

1 reference

12 December 2020

Comparative analysis of Ig and TCR gene rearrangements at diagnosis and at relapse of childhood precursor-B-ALL provides improved strategies for selection of stable PCR targets for monitoring of minimal residual disease

1 reference

12 December 2020

Successful rapid discontinuation of immunosuppressive therapy at molecular relapse after allogeneic bone marrow transplantation in a pediatric patient with myelodysplastic syndrome

1 reference

12 December 2020

Minimal residual disease in hematologic disorders

1 reference

12 December 2020

Diagnosis and monitoring of PML-RARalpha-positive acute promyelocytic leukemia by quantitative RT-PCR.

1 reference

12 December 2020

Concurrent detection of minimal residual disease (MRD) in childhood acute lymphoblastic leukaemia by flow cytometry and real-time PCR

1 reference

12 December 2020

Utility of WT1 as a reliable tool for the detection of minimal residual disease in children with leukemia

1 reference

12 December 2020

Minimal residual disease quantification in childhood acute lymphoblastic leukemia by real-time polymerase chain reaction using the SYBR green dye

1 reference

12 December 2020

Molecular follow up of donor lymphocyte infusion in CML children after allogeneic bone marrow transplantation

1 reference

12 December 2020

Detectable molecular residual disease at the beginning of maintenance therapy indicates poor outcome in children with T-cell acute lymphoblastic leukemia

1 reference

12 December 2020

Sequence analysis of clonal immunoglobulin and T-cell receptor gene rearrangements in children with acute lymphoblastic leukemia at diagnosis and at relapse: implications for pathogenesis and for the clinical utility of PCR-based methods of minimal r

1 reference

12 December 2020

Quantitative real-time RT-PCR monitoring of BCR-ABL in chronic myelogenous leukemia shows lack of agreement in blood and bone marrow samples

1 reference

12 December 2020

Minimal residual disease status before allogeneic bone marrow transplantation is an important determinant of successful outcome for children and adolescents with acute lymphoblastic leukemia.

1 reference

12 December 2020

Clonality profile in relapsed precursor-B-ALL children by GeneScan and sequencing analyses. Consequences on minimal residual disease monitoring

1 reference

12 December 2020

Pattern of immunoglobulin and T-cell receptor (Ig/TCR) gene rearrangements in Polish pediatric acute lymphoblastic leukemia patients--implications for RQ-PCR-based assessment of minimal residual disease

1 reference

12 December 2020

From gels to chips: "minisequencing" primer extension for analysis of point mutations and single nucleotide polymorphisms

1 reference

12 December 2020

Analysis of minimal residual disease in childhood acute lymphoblastic leukemia: comparison between RQ-PCR analysis of Ig/TcR gene rearrangements and multicolor flow cytometric immunophenotyping

1 reference

12 December 2020

Prognostic significance of WT1 gene expression in pediatric acute myeloid leukemia.

1 reference

12 December 2020

Molecular detection of minimal residual disease for patients with leukaemia and lymphoma

1 reference

12 December 2020

Acute promyelocytic leukemia: clinical relevance of two major PML-RAR alpha isoforms and detection of minimal residual disease by retrotranscriptase/polymerase chain reaction to predict relapse

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03194661

1 reference

15 August 2017

1 reference